A prospective, observational study to determine the incidence of moderate‐to‐severe hypophosphatemia in adults with inflammatory bowel disease trated with high‐dose intravenous iron
Latest Information Update: 05 Jul 2019
At a glance
- Drugs Ferric carboxymaltose (Primary) ; Ferric derisomaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Adverse reactions
Most Recent Events
- 05 Jul 2019 New trial record
- 02 Jul 2019 Results published in the Alimentary Pharmacology and Therapeutics